Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis

17 Oct 2022

Abstract excerpt

Background: Multiple sclerosis (MS) is a chronic, demyelinating, and immune-mediated disease of the central nervous system caused by a combination of genetic, epigenetic, and environmental factors. The incidence of MS has increased in the past several decades, suggesting changes in the environmental risk factors. Much effort has been made in the description of the gut microbiota in MS; however, little is known...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gut microbiota and health
Share to Immune Response and Inflammation
Share to Multiple Sclerosis Research Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36325343
DOI: 10.3389/fimmu.2022.960761

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosisPMID 36325343Read ↗

Microbiota-Driven Mechanisms in Multiple Sclerosis: Pathogenesis, Therapeutic Strategies, and Biomarker PotentialSemantic proximity Read ↗

Gut microbiota and gut-derived metabolites in defining multiple sclerosis phenotypic continuum.Semantic proximity Read ↗

Potential role of indolelactate and butyrate in multiple sclerosis revealed by integrated microbiome-metabolome analysisSemantic proximity Read ↗

Investigating the metabolite signature of an altered oral microbiota as a discriminant factor for multiple sclerosis: a pilot studySemantic proximity Read ↗

The gut microbiota in multiple sclerosis varies with disease activitySemantic proximity Read ↗

Microbial Influences on Amyotrophic Lateral Sclerosis: The Gut-Brain Axis and Therapeutic Potential of Microbiota ModulationSemantic proximity Read ↗

The Relationship Between Short-Chain Fatty Acid Secretion and Polymorphisms rs3894326 and rs778986 of the FUT3 Gene in Patients with Multiple Sclerosis-An Exploratory Analysis.Semantic proximity Read ↗

Gut flora in multiple sclerosis: implications for pathogenesis and treatmentSemantic proximity Read ↗

Microbiota Modulation in Patients with Metabolic SyndromeSemantic proximity Read ↗

The Gut Microbiota-Immunity Axis in ALS: A Role in Deciphering Disease Heterogeneity?Semantic proximity Read ↗

Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosisSemantic proximity Read ↗

Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.